HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2015 | 413 | 453 | 91.2% | |
| HF004 | 2016 | 477 | 519 | 91.9% | |
| HF004 | 2017 | 709 | 779 | 91.0% | |
| HF004 | 2018 | 881 | 950 | 92.7% | |
| HF004 | 2019 | 1015 | 1102 | 92.1% | |
| HF004 | 2020 | 1083 | 1181 | 91.7% | |
| HF004 | 2021 | 1251 | 1381 | 90.6% |
